Living Donor Liver Transplantation reduced Waitlist Mortality in Acute-on-chronic Liver Failure
- PMID: 40747906
- DOI: 10.1097/SLA.0000000000006866
Living Donor Liver Transplantation reduced Waitlist Mortality in Acute-on-chronic Liver Failure
Abstract
Objective: To compare intention-to-treat (ITT) and post-transplant outcomes of living donor liver transplant (LDLT) and deceased donor liver transplant (DDLT) in patients with acute-on-chronic liver failure (ACLF).
Summary background data: Limited data exist comparing LDLT and DDLT outcomes in ACLF, particularly addressing waitlist mortality.
Methods: Retrospective analysis of all ACLF patients listed for transplant (2008-2023). Patients with living donors were categorized as intention-to-treat LDLT (ITT-LDLT) group and others as ITT-DDLT group. Primary outcome was to compare ITT-overall survival (ITT-OS), defined as survival from listing to death. Secondary outcomes included waitlist outcomes, post-transplant complication and long-term survival.
Results: 270 patients were accepted for transplant (ITT-LDLT n=127, ITT-DDLT n=143) with similar clinical characteristics at listing. ITT-LDLT achieved superior ITT-OS, with 92.9% survival at 3 months vs. 67.1% for ITT-DDLT (P<0.001), driven by higher transplant rates (94.5% vs. 53.8%, P<0.001) and shorter waiting times. ACLF grade 2 and 3 patients had the greatest survival benefit in ITT analysis. Futile waitlist outcomes, defined as death or delisting were more common in ITT-DDLT (4.7% vs. 35.7%, P<0.001). Post-transplant outcomes were comparable; 30-day mortality (2.0% vs. 1.0%, P=0.62), severe complication (28.6% vs. 33.3%, P=0.47) and 5-year survival (74.5% vs. 74.7%, P=0.46). Even for ACLF grade 2 and 3, LDLT achieved a 5-year survival at 87.2% and 68.0% respectively. Older age, higher ACLF grade and ITT-DDLT predicted waitlist futility. Neither ACLF grades nor transplant type predicted graft survival.
Conclusion: ITT-LDLT improved ITT-OS especially in ACLF grade 2/3 cohort and provided similar perioperative and long-term outcomes to DDLT.
Keywords: acute-on-chronic liver failure; deceased donor liver transplant; liver transplant; living donor liver transplant; outcomes.
Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
Disclosure: The authors of this manuscript have no conflicts of interest to disclose.
Similar articles
-
Long-Term Survival Outcome Between Living Donor and Deceased Donor Liver Transplant for Hepatocellular Carcinoma: Intention-to-Treat and Propensity Score Matching Analyses.Ann Surg Oncol. 2019 May;26(5):1454-1462. doi: 10.1245/s10434-019-07206-0. Epub 2019 Feb 8. Ann Surg Oncol. 2019. PMID: 30737669
-
Intention-to-treat approach for survival benefit of ABO-incompatible living-donor liver transplantation in patients with high Model for End-stage Liver Disease scores.Hepatobiliary Surg Nutr. 2025 Jun 1;14(3):360-373. doi: 10.21037/hbsn-24-58. Epub 2024 Aug 2. Hepatobiliary Surg Nutr. 2025. PMID: 40529932 Free PMC article.
-
Survival benefit of living-donor liver transplantation in patients with a model for end-stage liver disease over 30 in a region with severe organ shortage: a retrospective cohort study.Int J Surg. 2023 Nov 1;109(11):3459-3466. doi: 10.1097/JS9.0000000000000634. Int J Surg. 2023. PMID: 37565633 Free PMC article.
-
Clinical outcomes after ABO-incompatible liver transplantation: A systematic review and meta-analysis.Transpl Immunol. 2021 Dec;69:101476. doi: 10.1016/j.trim.2021.101476. Epub 2021 Oct 1. Transpl Immunol. 2021. PMID: 34601097
-
Operative outcomes of adult living donor liver transplantation and deceased donor liver transplantation: a systematic review and meta-analysis.Liver Transpl. 2014 Apr;20(4):425-36. doi: 10.1002/lt.23836. Liver Transpl. 2014. PMID: 24478109
LinkOut - more resources
Full Text Sources